Ipamorelin 10mg

Ipamorelin is a synthetic pentapeptide GHRP that binds the growth hormone secretagogue receptor (GHS-R1a) with high selectivity, eliciting GH release without meaningful displacement of cortisol, prolactin or aldosterone in published models. Its clean receptor profile has positioned it as a reference compound in somatotropic axis and ghrelin-pathway studies. The 10mg presentation is intended for extended-duration protocols and multi-timepoint receptor characterisation.

Supplied as a lyophilised peptide vial, supplied for reconstitution with bacteriostatic water. The 10mg size suits extended dose-response studies, longitudinal GH-pulse monitoring and laboratories running parallel cohorts where larger working stocks deliver improved unit cost and protocol consistency.

Research Applications • Extended somatotropic axis and GH secretion profile studies • Long-duration ghrelin receptor desensitisation and tachyphylaxis research • Multi-cohort selectivity characterisation against earlier-generation GHRPs • Sustained combined GHRH-GHRP release-dynamics investigation

Specification • Identity: Ipamorelin (CAS 170851-70-4) • Molecular weight: 711.86 g/mol • Purity: 99%+ verified by HPLC and Mass Spectrometry • Format: lyophilised peptide vial — reconstitute with bacteriostatic water before use • Storage: store lyophilised at -20°C; once reconstituted, refrigerate at 2-8°C and use within 4-6 weeks; protect from light

For research use only — not for human consumption.